	US 11,964,962 B2
	Substituted pyridazinone compound and use thereof
Qingqiang Yao, Ji'nan (CN); Weilin Xie, Ji'nan (CN); Véronique Plantevin Krenitsky, Ji'nan (CN); Bo Liu, Ji'nan (CN); Yan Li, Ji'nan (CN); Ying Zhi, Ji'nan (CN); Ying Li, Ji'nan (CN); Yanling Mu, Ji'nan (CN); Jingyong Sun, Ji'nan (CN); Haiyang Wang, Ji'nan (CN); Zhongyu Wu, Ji'nan (CN); Haijiao Chen, Ji'nan (CN); Tiandi Ding, Ji'nan (CN); Yue Wang, Ji'nan (CN); Haoyi Sun, Ji'nan (CN); Feipeng Zhang, Ji'nan (CN); Peng Meng, Ji'nan (CN); Qingxu Liu, Ji'nan (CN); Huajie Li, Ji'nan (CN); Yige Wang, Ji'nan (CN); and Shanshan Wen, Ji'nan (CN)
Assigned to SHANDONG FIRST MEDICAL UNIVERSITY & SHANDONG ACADEMY OF MEDICAL SCIENCES, Ji'nan (CN)
Appl. No. 17/922,797
Filed by SHANDONG FIRST MEDICAL UNIVERSITY & SHANDONG ACADEMY OF MEDICAL SCIENCES, Ji'nan (CN)
PCT Filed Dec. 14, 2021, PCT No. PCT/CN2021/137854 § 371(c)(1), (2) Date Nov. 2, 2022, PCT Pub. No. WO2022/127779, PCT Pub. Date Jun. 23, 2022.
Claims priority of application No. 202011501355.0 (CN), filed on Dec. 17, 2020.
Prior Publication US 2023/0167091 A1, Jun. 1, 2023
Int. Cl. C07D 403/12 (2006.01); C07D 401/12 (2006.01)

CPC C07D 403/12 (2013.01) [C07D 401/12 (2013.01)]

2 Claims

1. A substituted pyridazinone compound selected from the group consisting of: